Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker

Blood

Volumn 114, Issue 14, 2009, Pages 3127-3130

  Piaggio, Giovanna ^a   Rosti, Vittorio ^b   Corselli, Mirko ^a   Bertolotti, Francesca ^a   Bergamaschi, Gaetano ^b   Pozzi, Sarah ^a   Imperiale, Davide ^a   Chiavarina, Barbara ^a   Bonetti, Elisa ^b   Novara, Francesca ^c   Sessarego, Mario ^d   Villani, Laura ^b   Garuti, Anna ^d   Massa, Margherita ^b   Ghio, Riccardo ^a   Campanelli, Rita ^b   Bacigalupo, Andrea ^a   Pecci, Alessandro ^c   Viarengo, Gianluca ^b   Zuffardi, Orsetta ^c   Frassoni, Francesco ^a   Barosi, Giovanni ^b   more..

^a UNIVERSITY OF GENOA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; MOLECULAR MARKER;

ADULT; AGED; ARTICLE; CELL CULTURE; CLONAL VARIATION; COLONY FORMING CELL; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION; MYELOPROLIFERATIVE DISORDER; PERIPHERAL BLOOD MONONUCLEAR CELL; PHILADELPHIA CHROMOSOME NEGATIVE CELL; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL;

ADULT; AGED; CELLS, CULTURED; CHRONIC DISEASE; COLONY-FORMING UNITS ASSAY; ENDOTHELIAL CELLS; FEMALE; FUSION PROTEINS, BCR-ABL; GENE REARRANGEMENT; HEMATOPOIETIC STEM CELLS; HUMANS; JANUS KINASE 2; MALE; MIDDLE AGED; MUTATION; MYELOPROLIFERATIVE DISORDERS; STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 70449468814     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-12-190991     Document Type: Article

References (21)

1. Gunsilius E, Duba H-C, Petzer AL, et al. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet. 2000;355(9216):1688-1691.
2. Fang B, Zheng C, Liao L, et al. Identification of human myelogenous leukaemia progenitor cells with hemangioblastic characteristics. Blood. 2005;105(7):2733-2740.
3. Oppliger Leibundgut E, Horn MP, Brunold C, et val. Hematopoietic and endothelial progenitor cell trafficking in patients with myeloproliferative diseases. Haematologica. 2006;91(11):1465-1472. (Pubitemid 44736112)
4. Choi K, Kennedy M, Kazarov A, Papadimitriou J, Keller G.Acommon precursor for hematopoietic and endothelial cells. Development. 1998;125(4):725-732. (Pubitemid 28108096)
5. Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S. Endothelial progenitor cells: new hope for a broken heart. Circulation. 2003;107(24):3093-3100. (Pubitemid 36758985)
6. Peichev M, Maiyer A, Pereira D, et al. Expression of VEGFR-2 and AC133 be circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 2000;95(3):952-958. (Pubitemid 30062717)
7. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;2759(5302):964-967. (Pubitemid 27087709)
8. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker P, Verfaillie C. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest. 2002;109(93):337-346. (Pubitemid 34141807)
9. Hur J, Yoon CH, Kim HS, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol. 2004;24(2):288-293. (Pubitemid 38197580)
10. Hill JM, Zalos G, Holcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348(7):593-600. (Pubitemid 36204953)
11. Ingram DA, Mead LE, Tanaka H, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood. 2004;104(9):2752-2760. (Pubitemid 39434958)
12. Ingram DA, Mead LE, Moore DB, Woodard W, Fenoglio A, Yoder MC. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood. 2005;105(7):2783- 2786. (Pubitemid 40446270)
13. Ingram DA, Caplice NM, Yoder MC. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood. 2005;106(5):1525-1531.
14. Yoder MC, Mead LE, Prater D, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood. 2007;109(5):1801-1809. (Pubitemid 46348173)
15. Massa M, Rosti V, Ferrario M, et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood. 2005;105(1):199-206. (Pubitemid 40053083)
16. Gabert J, Beillard E, van der Velden VH, et al. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia: a Europe Against Cancer program. Leukemia. 2003;17(12):2318-2357.
17. Barosi G, Bergamaschi G, Marchetti M, et al. JAK-2 mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis. Blood. 2007;110(12):4030-4036. (Pubitemid 350248459)
18. Baxter EJ, Scott LM, Campbel PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365(9464):1054- 1061. (Pubitemid 40386783)
19. Bernardo ME, Zaffaroni N, Novara F, et al. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res. 2007;67(19):9142-9149. (Pubitemid 47535900)
20. Takahashi N, Miura I, Saitoh K, Miura AB. Lineage involvement of stem cells bearing the Philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization. Blood. 1998;92(12):4758-4763. (Pubitemid 29005878)
21. Della Porta MG, Malcovati M, Rigolin GM, et al. Immunophenotypic, cytogenetic, and functional characterization of circulating endothelial cells in myelodysplastic syndromes. Leukemia. 2008;22(3):530-537.